Investigation of 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia

British Journal of Haematology

Volumn 110, Issue 4, 2000, Pages 801-812

  Mandal, C ^a   Chatterjee, M ^a   Sinha, D ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

9 O acetylated sialoglycoconjugates; Anti 9 O acetylated sialoglycoconjugates; Childhood acute lymphoblastic leukaemia (ALL); Minimal residual disease (MRD); Sialic acids

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE; DISACCHARIDE; GLYCOLIPID; GLYCOPROTEIN; MONOSACCHARIDE; MUCIN; N ACETYLGALACTOSAMINE; N ACETYLNEURAMINIC ACID; NEURAMINIC ACID DERIVATIVE; SIALIC ACID DERIVATIVE; SIALOGLYCOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; BIOLOGICAL MONITORING; BREAST CANCER; CARBOHYDRATE ANALYSIS; CHILD; CHILDHOOD LEUKEMIA; COLON CANCER; HEMATOPOIETIC CELL; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MELANOMA; PATHOGENESIS; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PSORIASIS; REVIEW; SCHOOL CHILD; ULCERATIVE COLITIS; VISCERAL LEISHMANIASIS;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHILD; FLUOROMETRY; GLYCOCONJUGATES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LYMPHOCYTES; NEOPLASM, RESIDUAL; SIALIC ACIDS;

EID: 0033766338     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02105.x     Document Type: Review

References (96)

1. Histochemical and genetic analysis of colonic mucin glycoproteins in Hirschsprung's disease
2. A single step purification of a sialic acid binding lectin (Achatinin H) from Achatina fulica snail
3. Chemical-modification studies of a unique sialic acid binding lectin from the snail Achatina Fulica
4. Analysis of Ig and T cell receptor genes in 40 childhood acute lymphoblastic leukaemias at diagnosis and subsquent relapse: Implications for the detection of minimal residual disease by polymerase chain analysis
5. Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia
6. Detection of minimal residual disease in acute leukaemia: Methodologic advances and clinical significance
7. 1 acid glycoprotein in wild type and multidrug resistant Chinese hamster ovary cell lines
8. Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: Its diagnostic and prognostic role
9. Diagnostic and prognostic potential of antibodies against O-acetylated sialic acids in canine visceral leishmaniasis
10. A monoclonal antibody recognizes an O-acetylated sialic acid in a human melanoma-associated ganglioside
11. Mucin degradation in the human colon: Production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria
12. The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin
13. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
14. O-acetylation and de-O-acetylation of sialic acids. 7- and 9-O-acetylation of alpha 2,6-linked sialic acids on endogenous N-linked glycans in rat liver Golgi vesicles
15. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP
16. 3LacCer) and to its 9-O-acetylated derivative
17. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils and monocytes
18. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry
19. Activation of alternative complement pathway
20. Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis
21. Changed expression of 9-O-acetyl GD3 (Cdw60) in benign and atypical proliferative lesions and carcinomas of human breast
22. Studies on the structure of the organ-specific determinant of human colonic mucin
23. Minimal residual disease analysis for the prediction of relapse in children with standard acute lymphoblastic leukaemia
24. Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides
25. Binding specificity of influenza C-virus to variably O-acetylated glycoconjugates and its use for histochemical detection of N-acetyl-9-O-acetylneuraminic acid in mammalian tissues
26. O-acetylation and de-O-acetylation of sialic acids. Purification, characterization, and properties of a glycosylated rat liver esterase specific for 9-O-acetylated sialic acids
27. Alterations of acyl-neuraminic acids on T-lymphocytes in cases of melanoma
28. Distribution of mono, di, and tri-O-acetylated sialic acids in normal and neoplastic colon
29. A prospective study of minimal residual disease in childhood B lineage acute lymphoblastic leukaemia; MRD level at the end of induction is a strong predictive factor of relapse
30. The nature of sialic acids in human lymphocytes
31. Sialic acids in molecular and cellular interactions
32. Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22
33. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation
34. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus
35. O-acetylation of sialic acids
36. 9-O acetylated sialic acids have widespread but selective expression: Analysis using a chimeric dual-function probe derived from Influenza C hemagglutinin-esterase
37. Binding of Plasmodium falciparum 175 kilodalton erythrocyte binding antigen and invasion of erythrocyte requires N-acetyl-neuraminic acid but not its O-acetylated form
38. Cdw60 antibodies bind to acetylated forms of gangliosides GD3
39. Cdw60 glycolipid antigens of human leucocytes: Structural characterization and cellular distribution
40. The D1.1 antigen: A cell surface marker for germinal cells of the central nervous system
41. A unique specificity of a sialic acid binding lectin Achatinin-H, from the haemolymph of Achatina fulica snail
42. Sialic acid binding lectins
43. Physicochemical studies on Achatinin-H, a novel sialic acid binding lectin
44. O-acetyl sialic acid binding lectin, as a probe for detection of subtle changes on the cell surface induced during acute lymphoblastic leukaemia (ALL) and its clinical application
45. Low O-acetytation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastasis
46. Gangliosides expressed in human breast cancer
47. Distribution of O-acetylated sialomucin in the normal and diseased gastrointestinal tract shown by a new monoclonal antibody
48. Developmental regulation of sialic acid modifications in rat and human colon
49. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukaemia
50. Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa
51. Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukaemia
52. Childhood leukaemias
53. Treatment of childhood leukaemias
54. Drug therapy: Acute lymphoblastic leukaemia
55. Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius
56. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin
57. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy
58. Differences between the O-acetylated sialic acids of the epithelial mucins of human colonic tumors and normal controls: A correlative chemical and histochemical study
59. Monoclonal antibodies to human colorectal epithelium: Markers for differentiation and tumour characterization
60. Cdw60: A marker for human CD8+ T helper cells
61. Measurement of residual leukaemia during remission in childhood acute lymphoblastic leukaemia
62. Influenza C virus uses 9-O-acetyl-N-acetyl neuraminic acid as a high affinity receptor determinant for attachment to cells
63. Chemistry, metabolism and biological function of sialic acids
64. Biosynthesis and function of N and O substituted sialic acids
65. Functional and biosynthetic aspects of sialic acid diversity
66. The specificity of the binding site of Achatinin-H, a sialic-acid binding lectin from Achatina Eulica
67. O-acetylated sialic acid - As a distinct marker between several leukaemia erythrocytes
68. Rapid diagnosis of visceral leishmaniasis using Achatinin(H), a 9-O-acetyl sialic acid binding lectin
69. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells
70. Regulation of sialic acid 9-O-acetylation during the growth and differentiation of murine erythroleukaemia cells
71. Sialic acid 9-O-acetylation on murine erythroleukaemia cells affects complement activation, binding to I-type lectins and tissue homing
72. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac (alpha 2-6) Gal/GalNAc sequence
73. Molecular dynamics-derived conformation and intramolecular interaction analysis of the N-acetyl-9-O-acetylneuraminic acid-containing ganglioside(GD1a) and NMR-based analysis of its binding to a human polyclonal immunoglobulin G fraction with selectivity for O-acetylated sialic acids
74. Identification of 9-O-acetyl sialoglycocnjugates (9-O-AcSGs) as biomarkers in childhood acute lymphoblastic leukaemia using a lectin, Achatinin H, as a probe
75. Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients acute lymphoblastic leukaemia
76. A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukaemia (ALL) employing Achatinin-H: A 9-O acetyl sialic acid binding lectin
77. A novel method for prognostic evaluation of childhood acute lymphoblastic leukaemia
78. Natural ligands of B cells adhesion molecule CD 22 beta can be masked by 9-O-acetylation of sialic acids
79. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule Cdw60 on normal keratinocytes
80. Electrophoretic mobility distributions of normal human T and B lymphoblasts and of peripheral blood lymphoblasts in acute lymphocytic leukaemia: Effects of neuraminidase and of solvent ionic strength
81. Altered expression of mucins throughout the colon in ulcerative colitis
82. Change in acylneuraminic acid content of T-lymphocytes and in plasma in breast cancer
83. Structure, function and metabolism of sialic acids
84. Diversity in the sialic acids
85. Sialic acids as ligands in recognition phenomena
86. An autosomal dominant gene regulates the extent of 9-O acetylation of murine erythrocyte sialic acids. A probable explanation for the variation in capacity to activate the human alternate complement pathway
87. The 9-O-acetylated disialosyl carbohydrate sequence of Cdw60 is a marker on activated human B lymphocytes
88. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked alpha-2,3 to penultimate galactose residues
89. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines
90. Purification and properties of a fucoidan-binding protein from human placenta and its identification as immunoglobulin G
91. Developmentally regulated O-acetylated sialoglycans in the central nervous system revealed by a new monoclonal antibody 493D4 recognizing a wide range of O-acetylated glycoconjugates
92. Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity
93. Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus
94. Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line